• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Moderna (MRNA)

Common Shares
Sell: $27.70|Buy: $27.75|Change: 0.23 (0.83%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Address

200 Technology Square
Cambridge
MA
USA
02139

Telephone

+1 617 7146500

Website

https://www.modernatx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Moderna Inc First Quarter Earnings Conference Call for 20262026-05-01T08:00:00
Moderna Inc First Quarter Earnings Results for 20262026-05-01T00:00:00
Moderna Inc Annual General Meeting for 20262026-04-30T08:00:00
Moderna Inc Annual Report for 20252026-02-20T00:00:00
Moderna Inc Fourth Quarter Earnings Conference Call for 20252026-02-13T08:00:00
Moderna Inc Fourth Quarter Earnings Results for 20252026-02-13T00:00:00
Moderna Inc Third Quarter Earnings Conference Call for 20252025-11-07T08:00:00
Moderna Inc Third Quarter Earnings Results for 20252025-11-07T00:00:00
Moderna Inc Second Quarter Earnings Conference Call for 20252025-08-01T08:00:00
Moderna Inc Second Quarter Earnings Results for 20252025-08-01T00:00:00
Moderna Inc First Quarter Earnings Conference Call for 20252025-05-01T08:00:00
Moderna Inc First Quarter Earnings Result for 20252025-05-01T00:00:00

Previous key dates

NameKey Date
Moderna Inc First Quarter Earnings Conference Call for 20252025-05-01T08:00:00
Moderna Inc First Quarter Earnings Result for 20252025-05-01T00:00:00
Moderna Inc Annual General Meeting for 20252025-04-30T08:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-11T13:30:00
TD Cowen 45th Annual Health Care Conference2025-03-05T09:10:00
Moderna Inc Annual Report for 20242025-02-21T00:00:00
Moderna Inc Fourth Quarter Earnings Conference Call for 20242025-02-14T08:00:00
Moderna Inc Fourth Quarter Earnings Result for 20242025-02-14T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T18:45:00
Piper Sandler 36th Annual Healthcare Conference2024-12-05T10:30:00
7th Annual Evercore ISI HealthCONx Conference2024-12-04T13:20:00
Moderna Inc Jefferies London Healthcare Conference 20242024-11-21T14:00:00
Moderna Inc UBS Global Healthcare Conference 20242024-11-13T15:30:00
Moderna Inc Guggenheim's Inaugural Healthcare Innovation Conference 20242024-11-12T10:00:00
Moderna Inc Third Quarter Earnings Conference Call for 20242024-11-07T08:00:00
Moderna Inc Third Quarter Earnings Result for 20242024-11-07T00:00:00
Investor Event - R&D Day and Business Updates2024-09-12T09:00:00
Moderna Inc Second Quarter Earnings Conference Call for 20242024-08-01T08:00:00
Moderna Inc Second Quarter Earnings Result for 20242024-08-01T00:00:00
Goldman Sachs 45th Annual Global Healthcare Conference2024-06-10T13:20:00
Jefferies Healthcare Conference2024-06-06T10:00:00
KCSA Cannabis Virtual Investor Conference2024-06-05T00:00:00
Moderna Oncology Investor Event2024-06-03T18:15:00
Bernstein's 40th Annual Strategic Decisions Conference2024-05-31T10:00:00
Moderna Inc Annual General Meeting for 20242024-05-06T08:00:00
Moderna Inc First Quarter Earnings Conference Call for 20242024-05-02T08:00:00
Moderna Inc First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.